195 related articles for article (PubMed ID: 14519675)
1. Adverse pregnancy outcome in users of sulfamethizole during pregnancy: a population-based observational study.
Ratanajamit C; Skriver MV; Nørgaard M; Jepsen P; Schønheyder HC; Sørensen HT
J Antimicrob Chemother; 2003 Nov; 52(5):837-41. PubMed ID: 14519675
[TBL] [Abstract][Full Text] [Related]
2. Pivmecillinam and adverse birth and neonatal outcomes: a population-based cohort study.
Vinther Skriver M; Nørgaard M; Pedersen L; Carl Schønheyder H; Sørensen HT
Scand J Infect Dis; 2004; 36(10):733-7. PubMed ID: 15513399
[TBL] [Abstract][Full Text] [Related]
3. Risk of adverse birth outcome and miscarriage in pregnant users of non-steroidal anti-inflammatory drugs: population based observational study and case-control study.
Nielsen GL; Sørensen HT; Larsen H; Pedersen L
BMJ; 2001 Feb; 322(7281):266-70. PubMed ID: 11157526
[TBL] [Abstract][Full Text] [Related]
4. Maternal use of fluconazole and risk of congenital malformations: a Danish population-based cohort study.
Nørgaard M; Pedersen L; Gislum M; Erichsen R; Søgaard KK; Schønheyder HC; Sørensen HT
J Antimicrob Chemother; 2008 Jul; 62(1):172-6. PubMed ID: 18400803
[TBL] [Abstract][Full Text] [Related]
5. A follow-up study of birth outcome in users of pivampicillin during pregnancy.
Larsen H; Nielsen GL; Sørensen HT; Møller M; Olsen J; Schønheyder HC
Acta Obstet Gynecol Scand; 2000 May; 79(5):379-83. PubMed ID: 10830765
[TBL] [Abstract][Full Text] [Related]
6. Birth outcome in women treated with azathioprine or mercaptopurine during pregnancy: A Danish nationwide cohort study.
Langagergaard V; Pedersen L; Gislum M; Nørgard B; Sørensen HT
Aliment Pharmacol Ther; 2007 Jan; 25(1):73-81. PubMed ID: 17229222
[TBL] [Abstract][Full Text] [Related]
7. Does miscarriage in an initial pregnancy lead to adverse obstetric and perinatal outcomes in the next continuing pregnancy?
Bhattacharya S; Townend J; Shetty A; Campbell D; Bhattacharya S
BJOG; 2008 Dec; 115(13):1623-9. PubMed ID: 18947339
[TBL] [Abstract][Full Text] [Related]
8. Fetal growth and adverse birth outcomes in women receiving prescriptions for acetaminophen during pregnancy. EuroMap Study Group.
Thulstrup AM; Sørensen HT; Nielsen GL; Andersen L; Barrett D; Vilstrup H; Olsen J
Am J Perinatol; 1999; 16(7):321-6. PubMed ID: 10614698
[TBL] [Abstract][Full Text] [Related]
9. The relationship between maternal periodontitis, adverse pregnancy outcome and miscarriage in never smokers.
Farrell S; Ide M; Wilson RF
J Clin Periodontol; 2006 Feb; 33(2):115-20. PubMed ID: 16441735
[TBL] [Abstract][Full Text] [Related]
10. Further analysis of the risk of adverse birth outcome after maternal use of fluoroquinolones.
Wogelius P; Nørgaard M; Gislum M; Pedersen L; Schønheyder HC; Sørensen HT
Int J Antimicrob Agents; 2005 Oct; 26(4):323-6. PubMed ID: 16144758
[TBL] [Abstract][Full Text] [Related]
11. Birth outcomes in pregnant women treated with low-molecular-weight heparin.
Sørensen HT; Johnsen SP; Larsen H; Pedersen L; Nielsen GL; Møller M
Acta Obstet Gynecol Scand; 2000 Aug; 79(8):655-9. PubMed ID: 10949230
[TBL] [Abstract][Full Text] [Related]
12. Plasminogen activator inhibitor activity, 4G5G polymorphism of the plasminogen activator inhibitor 1 gene, and first-trimester miscarriage in women with polycystic ovary syndrome.
Glueck CJ; Sieve L; Zhu B; Wang P
Metabolism; 2006 Mar; 55(3):345-52. PubMed ID: 16483878
[TBL] [Abstract][Full Text] [Related]
13. Caffeine consumption and the risk of reproductive hazards.
Leviton A
J Reprod Med; 1988 Feb; 33(2):175-8. PubMed ID: 3280787
[TBL] [Abstract][Full Text] [Related]
14. Coeliac disease in the father and risk of adverse pregnancy outcome: a population-based cohort study.
Ludvigsson JF; Montgomery SM; Ekbom A
Scand J Gastroenterol; 2006 Feb; 41(2):178-85. PubMed ID: 16484123
[TBL] [Abstract][Full Text] [Related]
15. Pre-pregnancy weight and the risk of stillbirth and neonatal death.
Kristensen J; Vestergaard M; Wisborg K; Kesmodel U; Secher NJ
BJOG; 2005 Apr; 112(4):403-8. PubMed ID: 15777435
[TBL] [Abstract][Full Text] [Related]
16. Threatened miscarriage as a predictor of obstetric outcome.
Johns J; Jauniaux E
Obstet Gynecol; 2006 Apr; 107(4):845-50. PubMed ID: 16582121
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic drug use in women with Crohn's disease and birth outcomes: a Danish nationwide cohort study.
Nørgård B; Pedersen L; Christensen LA; Sørensen HT
Am J Gastroenterol; 2007 Jul; 102(7):1406-13. PubMed ID: 17437503
[TBL] [Abstract][Full Text] [Related]
18. Use of acetaminophen during pregnancy and risk of adverse pregnancy outcomes.
Rebordosa C; Kogevinas M; Bech BH; Sørensen HT; Olsen J
Int J Epidemiol; 2009 Jun; 38(3):706-14. PubMed ID: 19332503
[TBL] [Abstract][Full Text] [Related]
19. Declines in low birth weight and preterm birth among infants who were born to HIV-infected women during an era of increased use of maternal antiretroviral drugs: Pediatric Spectrum of HIV Disease, 1989-2004.
Schulte J; Dominguez K; Sukalac T; Bohannon B; Fowler MG;
Pediatrics; 2007 Apr; 119(4):e900-6. PubMed ID: 17353299
[TBL] [Abstract][Full Text] [Related]
20. Use of benzodiazepines and benzodiazepine receptor agonists during pregnancy: neonatal outcome and congenital malformations.
Wikner BN; Stiller CO; Bergman U; Asker C; Källén B
Pharmacoepidemiol Drug Saf; 2007 Nov; 16(11):1203-10. PubMed ID: 17894421
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
